Clinical Trials Logo
  1. Home
  2. Impaired Cognition
  3. NCT02182817

Exposure to General Anaesthesia in Infancy and Neurocognitive Development — EGAIN  

Impaired Cognition Clinical Trial

Official title:
Prospective Cohort Study of Effects of Exposure to General Anaesthesia in Infancy on Neurocognitive Development

Clinical Trial Summary

This prospective cohort study aims to determine if apparently healthy children with no significant co-morbidities who undergo general anaesthesia for minor surgery before 15 months of age will develop measurable deficits in neurocognitive development compared to apparently healthy children with no significant co-morbidities who do not undergo general anaesthesia or surgery.

Clinical Trial Description

We hypothesize that healthy children exposed to general anaesthesia for minor surgery before 15 months of age will have significantly lower neurocognitive scores at 6,18, 24 and 36 months of age compared with age, and gender matched healthy children from the GUSTO cohort without prior exposure to general anaesthesia or surgery. (GUSTO: Growing Up Towards Healthy Outcomes in Singapore: a prospective longitudinal study providing normative data from the local population). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02182817
Study type Observational
Source KK Women's and Children's Hospital
Contact
Status Active, not recruiting
Phase
Start date November 2013
Completion date December 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT04006756 - A Study on Better Cognitive Functioning Through Braintraining on the Internet N/A
Active, not recruiting NCT02920632 - Cognitive Training in Parkinson Study N/A
Completed NCT01716975 - Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy Phase 3
Completed NCT01714661 - Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy Phase 3
Completed NCT01713491 - Pre-stroke Cognitive Status and Thrombolytic Therapy N/A
Recruiting NCT01315704 - Alzheimer's Disease and Related Disorders N/A
Completed NCT01315717 - Gait and Alzheimer Interaction Tracking (GAIT) Study N/A
Completed NCT01006330 - Dysphagia in Elderly Medical Patients Phase 4
Completed NCT01818778 - The Efficacy of Using Volunteers to Implement a Cognitive Stimulation Program in Two Long-Term Care Homes N/A
Recruiting NCT01314638 - Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio) N/A
Completed NCT01739933 - The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure Phase 3
Completed NCT02936401 - Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive Disorders N/A
Terminated NCT03095170 - Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder N/A
Terminated NCT03504501 - Synaptic Plasticity and Cognitive Function in RASopathies Phase 2
Completed NCT02723318 - The Impact of Family Financial Support on Cognition N/A
Recruiting NCT02290834 - Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer N/A
Completed NCT03064308 - The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery N/A
Completed NCT02265757 - Behavioral Interventions to Prevent or Delay Dementia N/A
Completed NCT01714713 - A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy Phase 3
Recruiting NCT01490567 - A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia Phase 4